PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: March 2020 Quarterly Update and Appendix 4C, page-3

  1. 110 Posts.
    lightbulb Created with Sketch. 5
    The two molecules have already shown promise in many malignancies. The cash position and ongoing trials with possible positive results should lift the share price in the near future.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.